Global Longlife Hospital & Research Limited has announced a key board appointment, naming Mr. Hiren Mandaliya as Additional Director in the Non-Executive Independent Director category. The appointment was approved during the company's Board of Directors meeting held on March 31, 2026, marking a significant addition to the hospital's leadership structure.

Board Meeting Details and Appointment Terms

The board meeting that approved this appointment took place on Tuesday, March 31, 2026, with the formal communication addressed to BSE Limited under the company's script code 543520. The appointment carries specific terms and conditions that reflect the company's governance framework.

Director Profile and Qualifications

Mr. Hiren Mandaliya brings substantial expertise to the board as a qualified Chartered Accountant. His professional background encompasses strong competencies in accounting, taxation, compliance management, finalization of accounts, filing of returns, assessment proceedings, and representation before tax authorities.

The company has confirmed that Mr. Mandaliya is not related to any existing director of the company, ensuring independence in his role. Additionally, he is not debarred from holding the office of Director by virtue of any SEBI order or any other regulatory authority.

Regulatory Compliance and Documentation

The appointment announcement was made in strict compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The formal disclosure was submitted pursuant to SEBI Master Circular no. HO/49/14/14(7)2025-CFDDPOD2/1/3762/2026 dated January 30, 2026.

Compensation and Governance Structure

As an Independent Director, Mr. Mandaliya will be compensated through sitting fees for attending Board and Committee meetings, as determined by the Board of Directors from time to time. This compensation structure aligns with standard practices for independent directors in corporate governance.

The company's registered office is located at 703, Sankalp Square, 3B, Beside Taj Skyline, Sindhu Bhavan Road, Ahmedabad – 380 059, Gujarat, India. Stakeholders can access detailed information regarding this appointment on the company's official website at www.globalhospital.co.in .

Dhruv Sureshkumar Jani, a promoter of Global Longlife Hospital & Research Limited, has disclosed the sale of 3,67,000 equity shares through open market transactions. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, dated January 20, 2026.

Transaction Details

The share sale was executed through open market transactions conducted between January 6, 2026, and January 16, 2026. The transaction represents a significant reduction in the promoter's stake in the healthcare company.

Shareholding Pattern Changes

The sale has resulted in a notable change in Jani's shareholding pattern in Global Longlife Hospital & Research Limited. His voting rights and equity stake have been proportionally reduced following the transaction.

Company Information

Global Longlife Hospital & Research Limited is listed on BSE Limited with equity script code 543520. The company's total equity share capital remains unchanged at ₹10.50 crores, consisting of 1,05,00,000 equity shares with a face value of ₹10 each.

Regulatory Compliance

The disclosure was submitted to BSE Limited in compliance with SEBI regulations governing substantial acquisition and disposal of shares. Dhruv Sureshkumar Jani, based in Ahmedabad, Gujarat, filed the necessary documentation as a promoter group member of the company. The transaction maintains transparency in shareholding changes as required under Indian securities regulations.